Mecasermin
- Part D specialty tier in 79% of formularies (2026Q3)
- Biologic
- Increlex
Therapy management checklist
Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.
Loading the therapy management checklist…
Storage and cold chain
Mecasermin: storage and handling
- Refrigerate
- Yes, as the label states
Label statement
Before Opening – Vials of INCRELEX are stable when refrigerated at 2° to 8°C (36° to 46°F).
- Freezing
- Do not freeze
Label statement
Avoid freezing the vials of INCRELEX.
- Room temperature
- No allowance stated
- Back into the refrigerator
- Not addressed
- Light
- Protect from light
Label statement
Protect from direct light.
- Shaking
- Not addressed
All storage statements on the label (13)
- Before Opening – Vials of INCRELEX are stable when refrigerated at 2° to 8°C (36° to 46°F).
- Avoid freezing the vials of INCRELEX.
- Protect from direct light.
- Expiration dates are stated on the labels.
- After Opening – Vials of INCRELEX are stable for 30 days after initial vial entry when stored refrigerated at 2° to 8°C (36° to 46°F).
- INCRELEX should not be used after its expiration date.
- Keep refrigerated and use within 30 days of initial vial entry.
- Remaining unused material should be discarded.
- Before Opening : Store new, unopened vials of INCRELEX in the refrigerator between 36°F to 46°F (2°C to 8°C).
- After Opening : Store opened vials of INCRELEX in the refrigerator between 36°F to 46°F (2°C to 8°C) for 30 days after you start using the vial.
- Do not freeze INCRELEX.
- If a vial freezes, throw it away.
- Do not use INCRELEX after the expiration date printed on the label.
FDA label version 5, effective May 18, 2026. DailyMed
Dosing and titration calendar
Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.
Loading dosing schedules…
Medicare Part D coverage
5,496 Part D plans, CMS formulary files 2026Q3. Look up tier, PA, step therapy and quantity limits by plan
Patient assistance
No manufacturer program page is listed for this drug yet.
Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.
For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.